Wagemans Michel F, Scholten Willem K, Hollmann Markus W, Kuipers Antonius H
Department of Anesthesiology, Pain Medicine and Palliative Care, Reinier de Graaf Hospital, Delft, the Netherlands.
Willem Scholten Consultancy, Medicines and Controlled Substances, Lopik, the Netherlands.
Minerva Anestesiol. 2020 Oct;86(10):1079-1088. doi: 10.23736/S0375-9393.20.14324-4. Epub 2020 May 18.
Epidural anesthesia has been considered the gold standard for perioperative analgesia, but the implementation of enhanced recovery after surgery (ERAS) protocols and a shift from open to laparoscopic surgery have diminished the advantage of epidural anesthesia. The authors summarize data from two newer meta-analyses and discuss the consequences for the role of epidural anesthesia (EA) in the perioperative setting. These meta-analyses enabled to distinguish between pre- and post-ERAS outcomes. Endpoints related to open and laparoscopic abdominal surgery were retrieved. General data, also applicable on abdominal surgery, were included. Data on other types of surgery were ignored. Two meta-analyses met the subject and inclusion criteria of the search. They demonstrate no difference between epidural analgesia and the control for most investigated endpoints. Analgesia employing epidural techniques is often not clinically superior to its alternatives; is associated with a small but relevant number of serious complications; and has a relatively high failure rate. Data show that the distinction between pre-ERAS and ERAS is essential for understanding the role of EA in intestinal surgery. Since ERAS was introduced, the advantages of epidural anesthesia vanished while the incidence of serious neurological complications is higher than previously thought. The authors conclude that epidural anesthesia in abdominal surgery has become less preferred and is limited to patients and types of surgery known to be accompanied with difficult pain management. This requires the use of other methods for analgesia, such as intravenous ketamine, peripheral nerve blocks, continuous wound infiltration, intrathecal morphine, and intravenous, and non-invasive PCA.
硬膜外麻醉一直被视为围手术期镇痛的金标准,但手术后加速康复(ERAS)方案的实施以及手术方式从开放手术向腹腔镜手术的转变,削弱了硬膜外麻醉的优势。作者总结了两项最新的荟萃分析数据,并讨论了硬膜外麻醉(EA)在围手术期作用的相关影响。这些荟萃分析能够区分ERAS实施前后的结果。检索了与开放和腹腔镜腹部手术相关的终点指标。纳入了也适用于腹部手术的一般数据。忽略了其他类型手术的数据。两项荟萃分析符合检索的主题和纳入标准。它们表明,对于大多数研究的终点指标,硬膜外镇痛与对照组之间没有差异。采用硬膜外技术的镇痛在临床上通常并不优于其替代方法;与少量但相关的严重并发症有关;并且失败率相对较高。数据表明,区分ERAS实施前和实施后对于理解EA在肠道手术中的作用至关重要。自引入ERAS以来,硬膜外麻醉的优势消失,而严重神经并发症的发生率高于先前的认识。作者得出结论,腹部手术中硬膜外麻醉已不再那么受青睐,仅限于已知伴有疼痛管理困难的患者和手术类型。这就需要使用其他镇痛方法,如静脉注射氯胺酮、外周神经阻滞、持续伤口浸润、鞘内注射吗啡以及静脉和非侵入性PCA。